Ophthalmology and Visual Sciences Archives
Sep. 10, 2020—Each year the Vanderbilt Eye Institute (VEI) sponsors a Discovery Grant program to highlight innovative research ideas initiated by its faculty.
Aug. 20, 2020—Anthony Daniels, MD, MSc, has been awarded a $300,000 Hyundai Hope On Wheels Scholar Grant to study the design of more precise drugs to treat retinoblastoma, the most common ocular cancer in children.
Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease
Jul. 20, 2020—Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.
Jul. 9, 2020—Research to Prevent Blindness (RPB) recently awarded a grant to investigators in Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.
May. 27, 2020—The Academy for Excellence in Education, established in 2007 to reinvigorate the education enterprise within Vanderbilt University and Vanderbilt University Medical Center, recently honored Geoffrey Fleming, MD, professor of Pediatrics, Critical Care Medicine and Janice Law, MD, assistant professor of Ophthalmology and Visual Sciences.
Mar. 12, 2020—During the recent Macula Society annual meeting, Paul Sternberg Jr., MD, G. W. Hale Professor of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute, received the organization’s highest honor, the Gass Medal for outstanding contributions in the study of macular diseases.
Nov. 21, 2019—Paul Sternberg Jr., MD, recently received the American Academy of Ophthalmology EnergEYES Award, given by the academy’s young ophthalmologists.
May. 22, 2019—When Josh Robinson, OD, chose to specialize in low vision optometry, he was certain of one thing — his services would have a big impact on his patient population — and it is proving to be true.
Nov. 29, 2018—Two Vanderbilt Eye Institute (VEI) researchers were recently awarded National Eye Institute (NEI) Audacious Goals Initiative (AGI) for Regenerative Medicine grants for $6.8 million over five years to develop new treatments for optic neuropathies and glaucoma, the leading cause of irreversible blindness.